AAAP 37th Annual Meeting and Scientific Symposium: Program & Speakers
161 sessions across 4 days with 202 confirmed speakers — the program for AAAP 37th Annual Meeting and Scientific Symposium, November 12–15, 2026 in Memphis, TN. From the official program; excludes exhibits and social events.
Featured speakers: Christina Brezing · Frances Levin · Margaret Haney · John Mariani · Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey · and 190 more below
No sessions match those filters. — or browse the full official program.
November 12, 2026
- 09:00–10:40SymposiumSymposium I - From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders
Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha
Reviews preclinical, observational and early randomized trial evidence on using GLP-1 receptor agonists to treat alcohol and other substance use disorders, including psychiatric safety.
Alcohol Use DisorderGLP-1 & Metabolic PsychiatrySubstance Use Disorders
- 13:30–14:30SymposiumMini Symposium - Tobacco Use and Its Impact on Psychiatric Symptoms and the Recovery from Other Substance Use Disorders
Maher Karam Hage · Jill Williams · Brian Hurley · Tony George
Covers the interplay between tobacco use and psychiatric symptoms, and how continued smoking affects recovery from other substance use disorders.
- 15:45–17:15WorkshopCourt-supervised Outpatient Commitment: Judges, Doctors, and Police discuss a case from PBS film
Kenneth Rosenberg · Alison Breaux · David Pool · Steven Foglesong · Laurence Westreich
Judges, physicians and police discuss court-supervised outpatient commitment using a case from a PBS film.
November 13, 2026
- 09:00–10:40SymposiumSymposium II - Neuromodulation to Treat Addictions: What’s Available and What’s in the Pipeline
Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey
Examines current and emerging neuromodulation approaches such as rTMS and focused ultrasound for treating substance use disorders, including personalization and response monitoring.
Neuromodulation (ECT, TMS)Drug Pipeline & Clinical TrialsSubstance Use Disorders
- 10:40–12:10SessionCase ConferenceAn ICD for Harm Reduction: Methadone-Associated Torsades de Pointes in a Patient With Opioid Use Disorder
Case of a man with opioid use disorder who developed torsades de pointes on methadone and other QT-prolonging exposures. Discusses withdrawal management, methadone retitration, and the decision to place a subcutaneous ICD as a harm reduction measure.
Drug Interactions & SafetyOpioid Use DisorderMedical Comorbidity & C-L Psychiatry
- 15:30–17:00Oral abstractLong-Acting Injectable Antipsychotics in Serious Mental Illness with Co-Occurring Substance Use: A Retrospective Cohort Study
Cohort study of long-acting injectable antipsychotic use in patients with serious mental illness and substance use.
Long-Acting InjectablesSerious Mental IllnessSubstance Use Disorders
- 15:30–17:00Oral abstractMedications for Opioid Use Disorder in VHA Acute Care Settings: A Quality Improvement Study
Quality improvement study of MOUD delivery in VHA acute care settings.
- 15:30–17:00Oral abstractNearcasting the Overdose Crisis: Key Insights from US Drug Dynamics
Presents near-real-time modeling of US overdose and drug supply trends.
- 15:30–17:00Oral abstractThe Overdose Crisis is Not Over: Race, Age, and Sex Disparities in Opioid-Related Acute Care, 2016–2023
Analyzes racial, age and sex disparities in opioid-related acute care use.
- 15:30–17:00Oral abstractPrize-based versus Voucher-based Contingency Management protocols for Stimulant-Opioid Co-Use: A Network Meta-Analysis
Network meta-analysis comparing prize- and voucher-based contingency management for stimulant-opioid co-use.
- 15:30–17:00Oral abstractSerious Mental Illness and Outcomes in Inpatient Detoxification and Rehabilitation: A Retrospective Cohort Study
Cohort study of how serious mental illness affects inpatient detoxification and rehabilitation outcomes.
- 15:30–17:00Oral abstractShort-Term Clinical Outcomes in Early Psychosis with and without Recent Substance Use: The Role of Urine Drug Screening and Antipsychotics in an Urban Youth Cohort
Looks at short-term outcomes in youth with early psychosis by recent substance use, urine drug screening and antipsychotic use.
Child & AdolescentSchizophrenia & PsychosisSubstance Use Disorders
- 15:30–17:00Oral abstractSubstance Use and Outcomes following Intramuscular Antipsychotic Treatment for Acute Pediatric Agitation: A Retrospective Cohort Study
Retrospective study of outcomes after intramuscular antipsychotics for pediatric agitation, by substance use status.
Antipsychotic PrescribingChild & AdolescentEmergency & Acute PsychiatrySubstance Use Disorders
- 15:30–17:00Oral abstractUsing Big Data to Monitor Substance-Related Morbidity in Hispanic/Latine Americans: A National Analysis, 2019–2023
National data analysis of substance-related morbidity among Hispanic/Latine Americans.
- 15:30–17:00Oral abstractWhen Prescribed Opioids Fail: Comparing Recall Patterns between Medications for Opioid Use Disorder versus Other Opioids Used for Pain
Compares product recall patterns for medications for opioid use disorder and opioids prescribed for pain.
- 15:30–17:00Oral abstractAbsolute and Relative Responses of Pharmacological Treatments for Gambling Disorder: A Systematic Review and Meta-Analysis
Meta-analysis of absolute and relative treatment responses to medications for gambling disorder.
- 15:30–17:00Oral abstractAssociations of Medical and Nonmedical Prescription Medication Use with Premature All-Cause Mortality Among US Adolescents
Examines how medical and nonmedical prescription medication use relates to early death among US adolescents.
- 15:30–17:00Oral abstractDifferential Retention by Substance Use Disorder Subtype in a Low-Barrier Walk-In Clinic: A Retrospective Cohort Study in Western Michigan
Retrospective study of treatment retention by substance use disorder type in a low-barrier walk-in clinic.
- 15:30–17:00Oral abstractFactors Associated with Detoxification Completion in an Urban Substance Use Treatment Unit
Identifies factors linked to completing detoxification in an urban treatment unit.
- 15:30–17:00Oral abstractHousing Status Reporting and Pooled Prevalence of People Experiencing Housing Instability in Opioid Use Disorder Pharmacotherapy Trials: A Systematic Review and Meta-analysis
Systematic review of how OUD medication trials report and include people with housing instability.
November 14, 2026
- 08:45–10:25SymposiumSymposium III - Beyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Discusses moving cannabis use disorder trials and clinical care from abstinence-only endpoints toward reduction-based, patient-centered outcome measures.
Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSubstance Use Disorders
- SessionLunch on Key Topics
Kevin Gray · Jeffrey DeVido · Stephen Ross · Frances Levin · Larissa Mooney · Richard Rosenthal · Kevin Sevarino · Amy Yule · Jennifer Creedon · Adina Bowe · Elie Aoun · Derek Blevins · Rebecca Payne · Laura Moss · Michael Gendel · Edwin Kim · Inbal Gafni · Maher Karam Hage · John Mariani · Tim Fong · Shelby Powers · Joseph Liberto · Jonathan Buchholz · Ismene Petrakis · Joao De Aquino · Edward Nunes
Small-table lunch discussions led by addiction experts on topics including cannabis, psychedelics, stimulant, alcohol and tobacco use disorders, co-occurring conditions, special populations, and career and mentorship opportunities.
November 15, 2026
- 08:00–09:30PosterAddictions Psychiatry Didactic & Simulation: A Best Practice Teaching Pilot
Pilot of didactic and simulation-based teaching in addiction psychiatry.
- 08:00–09:30PosterBeyond Weight Loss: GLP- 1 Receptor Agonists for Alcohol Use Disorder- A Systematic Review and Meta-Analysis
Systematic review and meta-analysis of GLP-1 agonists for AUD.
- 08:00–09:30PosterAge-Specific Substance Use Trends in the United States, 2015-2024: Is the Greatest Burden Still among Younger Adults?
Analysis of age-specific substance use trends in the US from 2015 to 2024.
- 08:00–09:30PosterBone Health Outcomes Among Patients with Opioid Use Disorder: Buprenorphine vs. Methadone Across Two Complementary Analyses
Compares bone health outcomes with buprenorphine versus methadone.
- 08:00–09:30PosterAlcohol Use Disorder and Binge Eating as Maladaptive Coping Strategies in a Young Adult with Autism Spectrum Disorder: A Case Study in the Complexity of Addiction at the Neurodevelopmental Interface
Case study of AUD and binge eating in a young adult with autism.
Alcohol Use DisorderAutism & Neurodevelopmental DisordersEating Disorders
- 08:00–09:30PosterBridging the Gap: Embedding Addiction Counselors in Inpatient Care to Improve Transitions of Care for Patients with Opioid Use Disorder (OUD)
Describes embedding addiction counselors in inpatient care to improve OUD transitions.
- 08:00–09:30PosterAlterations in Muscarinic Acetylcholine Type-1 Receptors in People with Cocaine Use Disorder
Study of M1 muscarinic receptor changes in people with cocaine use disorder.
- 08:00–09:30PosterCannabis Use and Psychosis: A Case Series Highlighting Risk Factors for Schizophrenia-Spectrum Disorders.
Case series on cannabis use and risk factors for schizophrenia-spectrum disorders.
- 08:00–09:30PosterAssociation between Cannabis-Related Disorders and Incident Psychosis in Individuals with Adhd
Examines cannabis-related disorders and new psychosis among people with ADHD.
- 08:00–09:30PosterCannabis Withdrawal Symptoms Can Occur Rapidly, be Severe and Bothersome, and Lead to Relapse in Daily/Near Daily Cannabis Users: Results of a Quantitative Cannabis User Survey
Survey results on cannabis withdrawal severity and relapse in frequent users.
- 08:00–09:30PosterCase Report: Transition from High-Dose Methadone to Buprenorphine over 14 Days on a Standard Medical Inpatient Unit
Case of switching from high-dose methadone to buprenorphine on a medical unit.
- 08:00–09:30PosterAssociation between Methadone Dose and Long-Term Retention in Patients Using Fentanyl
Relationship of methadone dose to long-term retention in patients using fentanyl.
- 08:00–09:30PosterChanges in Knowledge, Attitudes, and Perceptions about Substance Use among Early Middle School Students after Introduction of Substance Use Prevention Curriculum: A Pilot Study
Pilot of a prevention curriculum's effect on middle schoolers' substance use attitudes.
- 08:00–09:30PosterAssociations between Cumulative Adversity and Quality of Life: The Roles of Substance Use and Post-Traumatic Stress among People Experiencing Homelessness
Explores how adversity, substance use and PTSD relate to quality of life in people experiencing homelessness.
- 08:00–09:30PosterCharacterizing Causal Genetic Relationships among Substance Use, Psychiatric, and Physical Health Disorders
Genetic analysis of causal links among substance use, psychiatric and physical disorders.
- 08:00–09:30PosterBehind the Screen: How Social Media Can Help Treat Adolescent Substance Use Disorders
Considers social media as a tool in treating adolescent substance use.
Child & AdolescentDigital Psychiatry & AISubstance Use Disorders
- 08:00–09:30PosterChildhood Trauma and Motives for Cannabis Use in Individuals with Psychosis
Links childhood trauma to motives for cannabis use in people with psychosis.
Cannabis & CannabinoidsPTSD & TraumaSchizophrenia & Psychosis
- 08:00–09:30PosterBeyond Naloxone: A Hospital-Wide Harm Reduction Training Improves Resident Physician Knowledge, Confidence, and Attitudes Across Specialties
Evaluates a hospital-wide harm reduction training for resident physicians.
- 08:00–09:30PosterComparative Efficacy of Pharmacological Interventions for Benzodiazepine Discontinuation: A Systematic Review and Network Meta-Analysis
Network meta-analysis of drug strategies for benzodiazepine discontinuation.
- 08:00–09:30PosterHigh-Potency Cannabis as a Modifiable Risk Factor for Cannabis-Induced Psychosis in Adolescents and Young Adults
High-potency cannabis as a risk factor for psychosis in young people.
Cannabis & CannabinoidsChild & AdolescentSchizophrenia & Psychosis
- 08:00–09:30PosterEnhancing Psychiatry Resident Readiness for Management of Addiction Consults on Call
Efforts to prepare residents for on-call addiction consults.
- 08:00–09:30PosterContingency Management for Cannabis Use during Pregnancy: A Narrative Review.
Narrative review of contingency management for cannabis use in pregnancy.
- 08:00–09:30PosterImpact of Cannabis Legalization on Emergency Department Visits, Cannabis-Induced Psychosis, and Psychiatric Outcomes: A Community Hospital Analysis
Community hospital analysis of ED visits and psychosis after cannabis legalization.
- 08:00–09:30PosterExpanding the Therapeutic Landscape of Alcohol Use Disorder: Brenipatide (Dual GIP/GLP-1 Receptor Agonist) Clinical Trials
Overview of clinical trials of a dual GIP/GLP-1 agonist for AUD.
Alcohol Use DisorderGLP-1 & Metabolic PsychiatryDrug Pipeline & Clinical Trials
- 08:00–09:30PosterConvergence of Suicide Attempts, Nonsuicidal Self-Injury, and Substance Use in Adolescents: A Retrospective Study of an Outpatient Substance Use Treatment Population
Retrospective study of suicidality, self-injury and substance use in adolescents in treatment.
Child & AdolescentSubstance Use DisordersSuicide & Self-Harm
- 08:00–09:30PosterExtreme Sports and Its Association with Substance use: A Scoping Review
Scoping review of extreme sports participation and substance use.
- 08:00–09:30PosterImportance of Aggressive Early Treatment of Medetomidine Withdrawal
Argues for early, aggressive management of medetomidine withdrawal.
- 08:00–09:30PosterCracking the Black Box of the Illicit Drug Supply: Clinically Relevant Insights from Drug Checking Data in San Diego
Clinical insights from drug checking data on the San Diego illicit supply.
- 08:00–09:30PosterFeasibility of Multimodal In Vivo Assessment of Psilocybin in Opioid Use Disorder: A Case Series
Case series on feasibility of multimodal assessment of psilocybin in OUD.
- 08:00–09:30PosterImproving Identification and Treatment of Substance Use Disorders in Inpatient Psychiatry
Quality work on identifying and treating SUDs on inpatient psychiatry units.
- 08:00–09:30PosterCumulative Adverse Childhood Experiences and Patterns of Healthcare Utilization among California Adults: A State-Representative Analysis
Analysis of adverse childhood experiences and healthcare use among California adults.
- 08:00–09:30PosterFilling the gap in the adolescent substance use care continuum with thoughtful conversations
Addresses gaps in the adolescent substance use care continuum.
- 08:00–09:30PosterImproving Understanding and Reducing Barriers to Utilizing Varenicline for Smoking Cessation Treatment through Accessible Infographic
Infographic to reduce barriers to varenicline use for smoking cessation.
- 08:00–09:30PosterDesigning a Contingency Management App to Support Opioid Agonist Therapy
Design of a contingency management app to support opioid agonist therapy.
- 08:00–09:30PosterFrom Methadone 200 mg/day to Brixadi: Successful Inpatient Transition Using Low-Dose Buprenorphine Induction for Persistent QTc Prolongation
Case of transitioning from high-dose methadone to extended-release buprenorphine due to QTc prolongation.
Drug Interactions & SafetyLong-Acting InjectablesOpioid Use Disorder
- 08:00–09:30PosterImmuno-Endocrine Dynamics of Opioid Withdrawal Syndrome: A Narrative Review" to "Stress Hormone Dynamics of Opioid Withdrawal Syndrome: A Narrative Review
Narrative review of hormonal and stress-related dynamics in opioid withdrawal.
- 08:00–09:30PosterDetangling a Complex Network: A Framework and Components for Comprehensive Naloxone Community Distribution
Framework for comprehensive community naloxone distribution.
- 08:00–09:30PosterFrom Opioid Avoidance to Kratom Dependence: Treatment of Kratom Use Disorder with Long-Acting Injectable Buprenorphine
Case of kratom use disorder treated with long-acting injectable buprenorphine.
Long-Acting InjectablesOpioid Use DisorderSubstance Use Disorders
- 08:00–09:30PosterImpulsivity and Alcohol Use in Veterans with Co-occurring AUD and PTSD: Variations Before, During, and after Treatment
Tracks impulsivity and drinking in veterans with AUD and PTSD across treatment.
- 08:00–09:30PosterEffect of Tetrahydrocannabinol on Neural Reward Receipt in Young Adult Cannabis Users: A Randomized, Placebo-Controlled Study
Randomized placebo-controlled study of THC effects on neural reward response.
- 08:00–09:30PosterGLP-1 Receptor Agonists in Alcohol Use Disorder: Outcome-Domain Synthesis With Exploratory Aggregate-Data Pooling of Randomized Trials
Synthesis and pooling of randomized trials of GLP-1 agonists in AUD.
- 08:00–09:30PosterIncidence of Precipitated Withdrawal Following Rapid Initiation of Weekly and Monthly Extended-Release Injectable Buprenorphine in Adults With Moderate-to-Severe Opioid Use Disorder Not Currently Receiving Buprenorphine: A Study Protocol
Study protocol on precipitated withdrawal with rapid XR buprenorphine initiation.
Long-Acting InjectablesOpioid Use DisorderDrug Pipeline & Clinical Trials
- 08:00–09:30PosterEffect of L-Cysteine Supplementation on Acetaldehyde Exposure following Ethanol Administration: A Systematic Review and Meta-Analysis
Meta-analysis of L-cysteine on acetaldehyde exposure after ethanol.
- 08:00–09:30PosterHallucinogen Persisting Perception Disorder In An Adolescent: A Case Report
Case report of hallucinogen persisting perception disorder in an adolescent.
- 08:00–09:30PosterIncreasing Narcan Prescriptions at Discharge from Inpatient Psychiatry Admission at UConn Health through Implementation of an EMR Clinical Decision Support Alert
EMR alert to increase naloxone prescribing at psychiatric discharge.
- 08:00–09:30PosterEffects of Alcohol Use on Cognition During Later Adulthood
Examines alcohol use and cognition in later adulthood.
- 08:00–09:30PosterHidden in Plain Sight: Cocaine Induced Midline Destructive Lesions Misdiagnosed as Granulomatosis with Polyangiitis in a High Functioning Patient with 40 Years of Concealed Cocaine Use
Case of cocaine-induced midline lesions misdiagnosed as a vasculitis.
- 08:00–09:30PosterIntegrating Evidence-Based Co-Occurring Disorder Treatment and Wraparound Support in a Massachusetts Adult Treatment Court
Integrating co-occurring disorder treatment and wraparound support in a treatment court.
- 08:00–09:30PosterOptimizing Outreach and Engagement for Substance Use Disorder Training: An Analysis of Opioid Response Network (ORN) Strategies to Enhance Public Health Priorities
Analysis of outreach strategies used by the Opioid Response Network for SUD training.
- 08:00–09:30PosterMechanisms and Durability of Residential Treatment for Co-Occurring Gambling and Substance Use Disorders: A Mixed-Methods Eight-Year Follow-Up Study
Eight-year follow-up of residential treatment for gambling and substance use disorders.
- 08:00–09:30PosterIntravenous Use of Bupropion as a Cocaine Substitute: Examining its Acute Clinical Effects in a Psychiatric Crisis Center
Acute clinical effects of intravenous bupropion misuse seen in a crisis center.
Drug Interactions & SafetyEmergency & Acute PsychiatrySubstance Use Disorders
- 08:00–09:30PosterPerson-First Language in Statues for Commitment for Involuntary Substance Use Disorder Treatment
Reviews person-first language in involuntary SUD commitment statutes.
- 08:00–09:30PosterMedetomidine? What Happened to Xylazine?!?! A Case Example from Philadelphia and Literature Review
Case and literature review on medetomidine replacing xylazine in the drug supply.
- 08:00–09:30PosterIs There a Relationship between Rising ADHD Diagnoses and Methamphetamine Use Patterns?
Explores whether rising ADHD diagnoses relate to methamphetamine use patterns.
- 08:00–09:30PosterPosttraumatic Stress Symptoms, Medical Cannabis, and Pain Outcomes among Adults Prescribed Opioids
Links PTSD symptoms, medical cannabis and pain among adults prescribed opioids.
- 08:00–09:30PosterMedical Cannabis Knowledge and Clinical Readiness Among U.S. Medical Students
Assesses medical students' cannabis knowledge and clinical readiness.
- 08:00–09:30PosterKratom and 7OH: The 5th Wave of the Opioid Crisis
Overview of kratom and 7-OH as an emerging wave of the opioid crisis.
- 08:00–09:30PosterPredictors of Buprenorphine Retention following Emergency Department-Initiated Opioid Use Disorder Program
Predictors of buprenorphine retention after ED initiation.
- 08:00–09:30PosterMethadone Effect on Mood Compared to Other Opioid Agonist Therapies in Patients with Opioid Prescriptions: A Systematic Literature Review and Meta-Analysis
Meta-analysis of mood effects of methadone versus other opioid agonist therapies.
- 08:00–09:30PosterLaissez Les MOUD Rouler: Laying the Foundation for Emergency Department Buprenorphine Expansion in Louisiana Using the Bridge Starts Curriculum
Expanding ED buprenorphine in Louisiana using the Bridge Starts curriculum.
- 08:00–09:30PosterPredictors of Prolonged Boarding and Short-Term Psychiatric Emergency Service Revisits Among Veterans
Predictors of prolonged boarding and revisits to psychiatric emergency services among veterans.
- 08:00–09:30PosterMethylene Blue’s Clues: Misuse, Mania, and Malignant Catatonia
Case of methylene blue misuse with mania and malignant catatonia.
- 08:00–09:30PosterLarge Language Models Applied to Admissions Data May Identify Patients at High Risk for Alcohol Withdrawal Syndrome
Using LLMs on admission data to flag patients at risk of alcohol withdrawal.
- 08:00–09:30PosterPredictors of Readmission Following Inpatient Detoxification and Rehabilitation: The Role of Prior Treatment Utilization
Predictors of readmission after inpatient detox and rehab.
- 08:00–09:30PosterModerated and Unmoderated Digital Recovery Communities for Substance Use Disorders: A Systematic Review
Systematic review of moderated and unmoderated online recovery communities.
- 08:00–09:30PosterLatent Psychiatric Subtypes and Treatment Outcomes in Opioid Use Disorder: A Secondary Analysis of CTN-0094
Secondary analysis of psychiatric subtypes and OUD treatment outcomes.
- 08:00–09:30PosterPregabalin: A True Dual Diagnosis Medication? Perspectives from a Case of Successful Treatment with Pregabalin in a Patient with Comorbid Alcohol Use Disorder, Anxiety, and Primary Insomnia
Case of pregabalin treating co-occurring AUD, anxiety and insomnia.
- 08:00–09:30PosterMultivariable Prediction of Domain-Specific Reward Availability in Opioid Use Disorder: Mindfulness, Loneliness, and Sleep Quality as Independent Psychological Correlates
Psychological correlates of reward availability in OUD.
- 08:00–09:30PosterLearning Outcomes and Student Satisfaction in Motivational Interviewing Training: Real Patient versus Artificial Intelligence Mock Patient Experience
Compares motivational interviewing training with real versus AI mock patients.
- 08:00–09:30PosterPsilocybin Use, Mental Health Treatment Utilization, and Unmet Treatment Need Among US Individuals with Depression
Psilocybin use and treatment gaps among US adults with depression.
- 08:00–09:30PosterNational Trends in Management of Alcohol Withdrawal Syndrome across Vha following the Implementation of a Toolkit
National VHA trends in alcohol withdrawal management after a toolkit rollout.
- 08:00–09:30PosterReal-World Treatment Patterns of Patients Initiating Pharmacotherapy for Alcohol Use Disorder across Medicare, Medicaid, and Commercial Insurance
Claims-based look at AUD pharmacotherapy patterns across payer types.
- 08:00–09:30PosterThe Hottest Topic of Our Time: A Literature Review and Call to Action on Rising Heat and Substance Use Disorders
Literature review of heat and its impact on substance use disorders.
- 08:00–09:30PosterShort-Term Use of Kratom Resulting in Severe Hyponatremia: A Case Report.
Case of severe hyponatremia after short-term kratom use.
- 08:00–09:30PosterRecent Cocaine Use as a Predictor of 12-Month Treatment Engagement among Women Receiving Methadone Maintenance Treatment
Cocaine use as predictor of treatment engagement in women on methadone.
- 08:00–09:30PosterThe Opioid Response Networks Naloxone and Saturation Mapping Training for Tribes
Naloxone and saturation mapping training offered to tribal communities.
- 08:00–09:30PosterSingle and multiple tobacco product use among people with mental illness and substance use disorders: Findings from the National Surveys on Drug Use and Health, 2022-2024
National survey findings on tobacco product use among people with mental illness and SUD.
- 08:00–09:30PosterRecent Rapid Induction Techniques in Patients Transitioning from Methadone to Buprenorphine
Review of rapid induction methods for moving from methadone to buprenorphine.
- 08:00–09:30PosterSingle-Dose 7-Hydroxymitragynine Induced Psychosis and Delirium Requiring Intensive Care
Case of psychosis and delirium after a single dose of 7-hydroxymitragynine.
- 08:00–09:30PosterThe Socioeconomic Paradox of Substance Use: High Income and Education as Independent Risk Factors for Alcohol Use Disorder in U.S. Adults (2021-2024)
Examines income and education as risk factors for AUD.
- 08:00–09:30PosterTrends in Buprenorphine Prescribing by Provider Type and Patient Race in a Large Academic Health System, 2020-2025
Buprenorphine prescribing trends by provider type and patient race.
- 08:00–09:30PosterRecovery Capital Better Predicts Favorable Discharge Than Psychiatric Symptom Severity in Residential SUD Treatment
Recovery capital versus symptom severity as predictors of favorable discharge.
- 08:00–09:30PosterFrom Association to Function: Neuronal Knockdown of GWAS Candidate Genes Alters Methamphetamine Response in Drosophila
Tests GWAS candidate genes by neuronal knockdown in Drosophila to see effects on methamphetamine response.
- 08:00–09:30PosterUnderstanding the Trends in the National Survey on Gambling Attitudes and Gambling Experiences (NGAGE) across the Three Versions of the Survey
Trends in gambling attitudes and experiences across NGAGE survey versions.
- 08:00–09:30PosterSubstance Use Burden and Psychiatric Readmission following Long-Acting Injectable Antipsychotic Initiation
Substance use burden and readmission after starting LAI antipsychotics.
Long-Acting InjectablesSchizophrenia & PsychosisSubstance Use Disorders
- 08:00–09:30PosterRecurrent Cannabis Withdrawal-Associated Psychosis: A Case Report
Case of recurrent psychosis during cannabis withdrawal.
- 08:00–09:30PosterUnsupervised Anabolic Steroid Use in a Patient on Methadone Maintenance Therapy: A Case Report Highlighting Gaps in Care Coordination and the Role of Addiction Psychiatry
Case report of anabolic steroid use in a patient receiving methadone maintenance, highlighting care coordination gaps and the role of addiction psychiatry.
Collaborative & Integrated CareOpioid Use DisorderSubstance Use Disorders
- 08:00–09:30PosterSubstance Use Patterns and Clinical Complexity as Predictors of Psychiatric Readmission among Inpatients Receiving Long-Acting Injectable Antipsychotics
Predictors of readmission among inpatients on LAI antipsychotics.
Long-Acting InjectablesSchizophrenia & PsychosisSubstance Use Disorders
- 08:00–09:30PosterResident-as-Teacher on the Addiction Psychiatry Consult-Liaison Service
Resident-as-teacher approach on an addiction consult-liaison service.
- 08:00–09:30PosterSubstance Use Treatment Characteristics and Outcomes in U.S. General Psychiatry Residency Programs, 2015-2025
Substance use treatment characteristics in US psychiatry residency programs.
- 08:00–09:30PosterUse of Diazoxide in Management of Methadone-Induced Hypoglycemia
Describes using diazoxide to manage hypoglycemia attributed to methadone.
- 08:00–09:30PosterReversible Cardiogenic Shock and Multiorgan Dysfunction Following 7-Hydroxymitragynine Overdose in an Adolescent: A Case Report
Adolescent case of cardiogenic shock after 7-hydroxymitragynine overdose.
Child & AdolescentDrug Interactions & SafetySubstance Use Disorders
- 08:00–09:30PosterSuccessful Treatment of a Patient with Severe 7-OH Abuse and Chronic Psychosis.
Case of treating severe 7-OH use with chronic psychosis.
- 08:00–09:30PosterVirtual Reality-Based Psychedelic-Like Perceptual Alterations
Explores virtual reality approaches that produce perceptual changes resembling psychedelic experiences.
- 08:00–09:30PosterSevere Gambling Disorder Precipitated by Compounded Cyp Inhibition from Kratom and an Ssri in a Patient on Low-Dose Aripiprazole: A Novel Three-Way Pharmacokinetic Interaction
Case of gambling disorder attributed to a kratom, SSRI and aripiprazole interaction.
Antipsychotic PrescribingDrug Interactions & SafetySubstance Use Disorders
- 08:00–09:30PosterSupplementary Pathway for Medically Monitored Ibogaine for Opioid Use Disorder: A National Semi-Markov Cost-Effectiveness Analysis
Cost-effectiveness model of medically monitored ibogaine for OUD.
- 08:00–09:30PosterWhat is SR-17018? A Literature Review and Social Media Analysis of Real-World Use
Reviews the literature and social media discussion on real-world use of the compound SR-17018.
- 08:00–09:30PosterSex Differences in Pain Relief as the Primary Motivation for Prescription Pain Reliever Misuse among U.S. Adults, 2015-2024
Sex differences in pain relief motives for prescription pain reliever misuse.
- 08:00–09:30PosterThe Effects of Neuromodulation of craving, abstinence, mood, and Neurobiological Outcomes in Cocaine Use disorder: A Meta-Analytic Review
Meta-analysis of neuromodulation effects in cocaine use disorder.
- 08:00–09:30PosterWhen Muscle Relaxation Unravels: A Case of Tizanidine Withdrawal
Case of withdrawal following tizanidine use.
Deprescribing & PolypharmacyDrug Interactions & SafetySubstance Use Disorders
- 08:00–09:30PosterShort- And Long-Term Methadone Dose Trajectories in Patients Testing Positive versus Negative for Fentanyl at Treatment Initiation
Methadone dose trajectories by fentanyl status at treatment start.
- 08:00–09:30PosterWhen Psychiatry Changes the Stroke Workup: Nitrous Oxide Associated Mixed Arterial and Venous Thrombosis Presenting as Recurrent Stroke and Central Auditory Dysfunction
Case of nitrous oxide use linked to arterial and venous thrombosis presenting as recurrent stroke.
- 08:00–09:30PosterBeyond the Biomarker: Structural and Linguistic Equity in Fitness-To-Drive Medical Assessment via Dichotomous Questionnaires
Looks at equity and language in questionnaire-based fitness-to-drive assessment.
- 08:00–09:30PosterComparative Analysis of State Policy Responses to Emerging Adulterants Xylazine and Medetomidine
Compares state policy responses to xylazine and medetomidine adulterants.
- 08:00–09:30PosterLegal, Intoxicating and Safe: A Pre-Prohibition Content Analysis of Hemp-Derived Novel Cannabinoid Marketing
Content analysis of marketing for hemp-derived novel cannabinoids.
- 08:00–09:30PosterOcular Complications, Withdrawal, and Successful Naltrexone Treatment in Kratom Use Disorder: A Case Report
Kratom use disorder case with ocular complications treated with naltrexone.
- 08:00–09:30Poster48-Hour Transdermal Buprenorphine Induction to Initiate Extended-Release Buprenorphine for the Management of Opioid Use Disorder in an Outpatient setting: A Retrospective Case Series
Case series on using transdermal buprenorphine over 48 hours to start extended-release buprenorphine in outpatients with OUD.
- 08:00–09:30PosterLife-Threatening Cardiotoxicity from Chronic High-Dose Loperamide Misuse: A Case Report
Case of serious cardiotoxicity from chronic loperamide misuse.
Drug Interactions & SafetyOpioid Use DisorderSubstance Use Disorders
- 08:00–09:30Poster7-Hydroxymitragynine Dependence with Severe Functional Impairment: Rapid Stabilization on Buprenorphine/Naloxone
Case describing rapid stabilization of 7-hydroxymitragynine dependence with buprenorphine/naloxone.
- 08:00–09:30PosterOnline Sports Betting and Gambling Risk in Brazil: Nationally Representative Findings and Implications for Addiction Psychiatry
National Brazilian data on online sports betting and gambling risk.
- 08:00–09:30PosterMapping the Opioid Crisis: County-Level Hotspots, Cold Spots, and the Geographic Divide in U.S. Overdose Mortality (2021-2023)
County-level geographic analysis of US overdose mortality.
- 08:00–09:30PosterA Novel Intervention for Opioid Overdose Survivors: Engaging and Retaining in Treatment
Intervention to engage and retain opioid overdose survivors in treatment.
- 08:00–09:30PosterA Qualitative Study on the Experiences, Barriers, and Understanding of Opioid Agonist Treatment Among Youth with Opioid Use Disorder in Vancouver, British Columbia
Qualitative study of youth experiences and barriers with opioid agonist treatment.
- 08:00–09:30PosterI Heard My Story: A Qualitative Study of Recovery Experiences in Crystal Meth Anonymous
Qualitative study of recovery experiences among members of Crystal Meth Anonymous.
- 08:00–09:30PosterAccelerated Resolution Therapy as an Adjunctive Treatment Modality for Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder: A Scoping Review
Scoping review of accelerated resolution therapy for co-occurring AUD and PTSD.
- 08:00–09:30PosterAcceptability and Feasibility of Optimo (Onsite Ptsd Treatment to Improve MOUD Outcomes): An Open Label Pilot of Adapted Cognitive Processing Therapy Delivered at Syringe Services Programs
Pilot of adapted cognitive processing therapy for PTSD delivered at syringe services programs.
- 08:00–09:30PosterAcute Psychosis and Opioid Withdrawal Associated with 7-Hydroxymitragynine Use: A Case Report
Case report of psychosis and opioid withdrawal linked to 7-hydroxymitragynine.
- 08:00–09:30PosterPsychiatric Destabilization following Bufo (5-MeO-DMT) Exposure in a Patient with Pre-Existing PTSD: A Case Report
Case of psychiatric destabilization after 5-MeO-DMT in a patient with PTSD.
- 08:00–09:30PosterPsychosis or Encephalopathy? Addiction Psychiatry Challenges in Co-Occurring Schizophrenia, Alcohol Use Disorder, and Decompensated Liver Disease
Case distinguishing psychosis from hepatic encephalopathy in schizophrenia with AUD.
Alcohol Use DisorderSchizophrenia & PsychosisMedical Comorbidity & C-L Psychiatry
Schedule to be announced
- SymposiumSymposiaBeyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Argues for moving beyond abstinence as the sole endpoint in cannabis use disorder trials, discussing reduction-based and patient-centered outcome measures.
Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSubstance Use Disorders
- SymposiumSymposiaFrom Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders
Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha
Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.
Alcohol Use DisorderGLP-1 & Metabolic PsychiatrySubstance Use Disorders
- SymposiumSymposiaNeuromodulation to Treat Addictions: What's Available and What's in the Pipeline
Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey
Reviews current and investigational neuromodulation techniques for substance use disorders, including rTMS and focused ultrasound.
Neuromodulation (ECT, TMS)Drug Pipeline & Clinical TrialsSubstance Use Disorders
- SymposiumMini SymposiumTobacco Use and Its Impact on Psychiatric Symptoms and the Recovery from Other Substance Use Disorders
Maher Karam Hage · Jill Williams · Brian Hurley · Tony George
Examines how ongoing tobacco use interacts with psychiatric symptoms and recovery from other substance use disorders.
- LectureMedical UpdateHormone Therapy for Perimenopause and Menopause
Evidence-based update on hormone replacement therapy for perimenopausal and menopausal patients, covering indications, contraindications, risk stratification, formulations, and monitoring.
- WorkshopWorkshopsAddiction, Hope, and Recovery in Tolkien's the Lord of the Rings
Uses Tolkien's fiction as a lens for discussing addiction, hope, and recovery themes with patients and trainees.
- WorkshopWorkshopsAges 11–17: Understanding the Social Drivers of Early Substance Use Through Interactive Cases
Philipa Owusu-Antwi · Sandra Gomez-Luna · Adina Bowe
Interactive case discussions on the social and environmental drivers of substance use initiation in early adolescence.
- WorkshopWorkshopsAnyone Can Treat! Building Confidence in Treating Youth Cannabis Use Disorder
Gerald Busch · Ravi Shankar · Cathryn A. Galanter
Builds general clinicians' confidence and skills in treating cannabis use disorder in adolescents.
Cannabis & CannabinoidsChild & AdolescentSubstance Use Disorders
- WorkshopWorkshopsCOMMITTED: A New PBS Series on Outpatient Commitment
Kenneth Rosenberg · Alison Breaux · David Pool · Steven Foglesong · Laurence Westreich
Screens and discusses a PBS documentary series on outpatient commitment, with perspectives from psychiatrists, judges, and law enforcement.
Emergency & Acute PsychiatryForensic & CorrectionalSerious Mental Illness
- WorkshopWorkshopsDefending Your Knowledge: Preparation for serving as a forensic psychiatrist in legal issues about addictions and substance use
Prepares clinicians to serve as forensic experts and give testimony in addiction-related legal proceedings.
- WorkshopWorkshopsFrom Plant to Patient: Navigating the Evidence, Risks, and Counseling of Medical Cannabis
Elizabeth McCord · Yilang Tang · Karen Drexler · Michael Hsu
Reviews the evidence base, risks, and patient-counseling approaches surrounding medical cannabis.
- WorkshopWorkshopsHow Do We Keep Them? Teaching, Mentoring, and Retaining the Addiction Workforce
Akhil Anand · Christopher Blazes · Manassa Hany
Tackles recruitment, mentorship, and retention challenges in the addiction psychiatry workforce.
Education & TrainingPractice, Policy & WorkforceSubstance Use Disorders
- WorkshopWorkshopsImproving Emergency Department Protocols of Care for Overdose Survivors Using Suicide Prevention Frameworks
Joan Chen · Amira Athanasios · Jessica Sainz
Adapts suicide prevention frameworks to strengthen emergency department care pathways for overdose survivors.
Emergency & Acute PsychiatryOpioid Use DisorderSuicide & Self-Harm
- WorkshopWorkshopsINTERVENTION! When, Why, and How to Make the Call — Navigating Difficult Cases in Private Practice: Pros, Cons, and Pitfalls
Lisa Goldfarb · Stephen Ross · Cindy Feinberg · Amy Swift · Matthew Rottnek
Explores when and how to initiate formal interventions in private addiction practice, including risks and pitfalls.
- WorkshopWorkshopsKratom 2.0: High-Potency Alkaloids and Emerging Clinical Syndromes
Covers high-potency kratom alkaloid products and the new clinical syndromes and management questions they raise.
- WorkshopWorkshopsPeer Review Bootcamp: What Does It Mean to Be a "good reviewer" for Academic journals?
MacKenzie Peltier · Ismene Petrakis · Justine W. Welsh · Carla Marienfeld · Declan Barry
Hands-on training in performing high-quality peer review for academic journals.
- WorkshopWorkshopsThe Epidemic in Your Pocket—Stopping the Gamblification of Everything through Education and Advocacy
Addresses the spread of gambling mechanics into everyday technology and how clinicians can respond through education and advocacy.
Digital Psychiatry & AIPractice, Policy & WorkforceSubstance Use Disorders
- WorkshopWorkshopsThe Role of Self-Disclosure in the Practice of Addiction Psychiatry
John Mariani · Charles Silberstein · Lisa Goldfarb
Examines when and how clinician self-disclosure can be used therapeutically in addiction treatment.
- WorkshopWorkshopsThe Vagus Nerve and Neurostimulation for Opioid Use Disorder and Chronic Pain
Zev Schuman-Olivier · Alta DeRoo
Explores vagus nerve stimulation and related neurostimulation approaches for opioid use disorder and chronic pain.
- WorkshopWorkshopsWhat Are You Smoking?: Addressing Nicotine and Cannabis Use in Adolescents
Jennifer Creedon · Britney Lambert · Kimberly Rousseau
Assessment and treatment strategies for nicotine and cannabis use among adolescents.
Cannabis & CannabinoidsChild & AdolescentSubstance Use Disorders
Never miss an early-bird deadline
One-click alerts for this conference — we email you 14 and 3 days before each deadline:
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Chicago (5)
- Illinois (5)
- San Diego (5)
- Colorado (4)
- Florida (4)
- Denver (3)
- Louisiana (3)
- New Orleans (3)
- New Zealand (3)
- Reston (3)
- Texas (3)
- Virginia (3)
- Austin (2)
- Australia (2)
- Hawaii (2)
- New York (2)
- Orlando (2)
- Washington (2)
- Washington, D.C. (2)
- Adelaide (1)
- Albuquerque (1)
- Arizona (1)
- Asheville (1)
- Atlanta (1)
- Auckland (1)
- Bahamas (1)
- Baltimore (1)
- Barcelona (1)
- Boston (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Cartagena (1)
- Christchurch (1)
- Cincinnati (1)
- Colombia (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Georgia (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Massachusetts (1)
- Minneapolis (1)
- Minnesota (1)
- Montreal (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- North Carolina (1)
- Ohio (1)
- Paradise Island (1)
- Queenstown (1)
- Rio de Janeiro (1)
- San Francisco (1)
- Scottsdale (1)
- South Africa (1)
- Spain (1)
- Tennessee (1)
- Thredbo Village (1)
- United Kingdom (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry